Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Danaher Corporation

Danaher Corporation (DHR-PA) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

DHR-PA●NYSE
HealthcareMedical - Diagnostics & Research
$1841.01
$50.76(2.68%)
U.S. Market opens in 12h 43m

Danaher Corporation (DHR-PA)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio35.08
EPS (TTM)$7.88
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

DHR-PA Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Danaher Corporation (NYSE: DHR-PA) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Danaher Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DHR-PA on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NYSE listing.

Key metrics behind Danaher Corporation's NYSE-traded stock include a P/E ratio of 35.08 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of DHR-PA on the NYSE.

Price Performance (NYSE: DHR-PA)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

https://www.danaher.com
202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

780,000 Employees
IPO DateFeb 27, 2019
CountryUS

Frequently Asked Questions